-
1 Comment
Protech Home Medical Corp is currently in a long term downtrend where the price is trading 2.2% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.5.
Protech Home Medical Corp's total revenue sank by 0.1% to $23M since the same quarter in the previous year.
Its net income has increased by 113.0% to $229K since the same quarter in the previous year.
Finally, its free cash flow fell by 44.3% to $2M since the same quarter in the previous year.
Based on the above factors, Protech Home Medical Corp gets an overall score of 2/5.
| Exchange | V |
|---|---|
| CurrencyCode | CAD |
| ISIN | CA74880P1045 |
| Sector | Healthcare |
| Industry | Medical Devices |
| PE Ratio | None |
|---|---|
| Market Cap | 233M |
| Target Price | 12.27 |
| Beta | 2.13 |
| Dividend Yield | 0.0% |
Protech Home Medical Corp. provides in-home monitoring equipment, supplies, and services for patients in the United States. It offers daily and ambulatory aides; power mobility equipment; BiPAP and CPAP machines, oxygen concentrators, and ventilators; oxygen therapy; sleep apnea and PAP treatment equipment; disease management services; and home ventilator equipment, as well as rents respiratory equipment. The company was formerly known as Patient Home Monitoring Corp. and changed its name to Protech Home Medical Corp. in April 2018. Protech Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for PTQ.V using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
